Found: 71
Select item for more details and to access through your institution.
Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 871, doi. 10.1002/ajh.27263
- By:
- Publication type:
- Article
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 193, doi. 10.1002/ajh.27138
- By:
- Publication type:
- Article
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo‐Moffitt study of 156 informative cases.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. E76, doi. 10.1002/ajh.26845
- By:
- Publication type:
- Article
Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E28, doi. 10.1002/ajh.26786
- By:
- Publication type:
- Article
A dynamic 3‐factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. 1127, doi. 10.1002/ajh.26630
- By:
- Publication type:
- Article
Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. 1013, doi. 10.1002/ajh.26589
- By:
- Publication type:
- Article
Real‐world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. E214, doi. 10.1002/ajh.26539
- By:
- Publication type:
- Article
A population‐based study of acute panmyelosis with myelofibrosis in the United States: 2004–2015.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E144, doi. 10.1002/ajh.26467
- By:
- Publication type:
- Article
Midostaurin therapy for indolent and smoldering systemic mastocytosis: Retrospective review of Mayo Clinic experience.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E138, doi. 10.1002/ajh.26464
- By:
- Publication type:
- Article
Sustained, complete response to pexidartinib in a patient with CSF1R‐mutated Erdheim–Chester disease.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 293, doi. 10.1002/ajh.26441
- By:
- Publication type:
- Article
A population‐based study of outcomes in polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the United States from 2001 to 2015: Comparison with data from a Mayo Clinic single institutional series.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. E464, doi. 10.1002/ajh.26377
- By:
- Publication type:
- Article
Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. 1604, doi. 10.1002/ajh.26355
- By:
- Publication type:
- Article
Single‐agent cladribine as an effective front‐line therapy for adults with Langerhans cell histiocytosis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E146, doi. 10.1002/ajh.26119
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1511, doi. 10.1002/ajh.25978
- By:
- Publication type:
- Article
A population‐based study of chronic eosinophilic leukemia‐not otherwise specified in the United States.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 10, p. E257, doi. 10.1002/ajh.25906
- By:
- Publication type:
- Article
The differential diagnosis of basophilia in patients undergoing BCR‐ABL testing.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 9, p. E216, doi. 10.1002/ajh.25830
- By:
- Publication type:
- Article
Cutaneous blastic plasmacytoid dendritic cell neoplasm arising in the context of TET2 and ZRSR2 mutated clonal cytopenias of unknown significance, secondary to somatic copy number losses involving CDK2NA/2NB and MTAP.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 2, p. E31, doi. 10.1002/ajh.25675
- By:
- Publication type:
- Article
The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 11, p. E355, doi. 10.1002/ajh.25239
- By:
- Publication type:
- Article
Never Say Die: Survival Signaling in Large Granular Lymphocyte Leukemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S244, doi. 10.3816/CLM.2009.s.019
- By:
- Publication type:
- Article
Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
Neurological Manifestations of Histiocytic Disorders.
- Published in:
- Current Neurology & Neuroscience Reports, 2023, v. 23, n. 6, p. 277, doi. 10.1007/s11910-023-01272-4
- By:
- Publication type:
- Article
Genetic and Genomic Landscape of Secondary and Therapy-Related Acute Myeloid Leukemia.
- Published in:
- Genes, 2020, v. 11, n. 7, p. 749, doi. 10.3390/genes11070749
- By:
- Publication type:
- Article
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00922-7
- By:
- Publication type:
- Article
The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma undergoing autologous stem cell transplant.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00920-9
- By:
- Publication type:
- Article
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00821-x
- By:
- Publication type:
- Article
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00818-6
- By:
- Publication type:
- Article
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00812-y
- By:
- Publication type:
- Article
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- 2023
- By:
- Publication type:
- Letter
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00821-x
- By:
- Publication type:
- Article
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Published in:
- 2023
- By:
- Publication type:
- Letter
Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Clinical and therapeutic implications of BRAF fusions in histiocytic disorders.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00693-7
- By:
- Publication type:
- Article
Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00691-9
- By:
- Publication type:
- Article
Clinical features and outcomes of non-pulmonary unifocal adult Langerhans cell histiocytosis.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00685-7
- By:
- Publication type:
- Article
Acute seizures and status epilepticus in immune effector cell associated neurotoxicity syndrome (ICANS).
- Published in:
- 2022
- By:
- Publication type:
- Letter
Isolated anemia in patients with large granular lymphocytic leukemia (LGLL).
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 2, p. 1, doi. 10.1038/s41408-022-00632-6
- By:
- Publication type:
- Article
A novel Iowa–Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome prediction.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 11, p. 1, doi. 10.1038/s41408-021-00573-6
- By:
- Publication type:
- Article
Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Prognostic impact and timing considerations for allogeneic hematopoietic stem cell transplantation in chronic myelomonocytic leukemia.
- Published in:
- 2020
- By:
- Publication type:
- Letter
A population-based study of chronic neutrophilic leukemia in the United States.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Bilateral Intrusion of Molar using Modified transpalatal Arch in Mutilated Case.
- Published in:
- Journal of Indian Orthodontic Society, 2014, v. 48, n. 4, p. 280, doi. 10.1177/0974909820140411
- By:
- Publication type:
- Article
Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experience.
- Published in:
- Oncologist, 2022, v. 27, n. 2, p. 144, doi. 10.1093/oncolo/oyab031
- By:
- Publication type:
- Article
Efficacy of BRAF‐Inhibitor Therapy in BRAF<sup>V600E</sup>‐Mutated Adult Langerhans Cell Histiocytosis.
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. 1001, doi. 10.1002/onco.13541
- By:
- Publication type:
- Article
Emerging role of CEBP-α mutations in acute myeloid leukemia.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Role of Germline Predisposition to Therapy-Related Myeloid Neoplasms.
- Published in:
- Current Hematologic Malignancy Reports, 2022, v. 17, n. 6, p. 254, doi. 10.1007/s11899-022-00676-2
- By:
- Publication type:
- Article